Ticker
INMCompany Name
INMED PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Gross Profit | Gross Profits to Assets |
---|---|---|---|
6/30/2025 | $ 15.58M | $ 1.71M | 10.95% |
3/31/2025 | $ 9.28M | $ 1.6M | 17.2% |
12/31/2024 | $ 8.5M | $ 1.71M | 20.11% |
9/30/2024 | $ 10.47M | $ 1.57M | 15.03% |
6/30/2024 | $ 11.82M | $ 1.1M | 9.31% |
3/31/2024 | $ 13.36M | $ 2.21M | 16.51% |
12/31/2023 | $ 15.26M | $ 2.11M | 13.82% |
9/30/2023 | $ 10.92M | $ 1.92M | 17.54% |
6/30/2023 | $ 14.11M | $ 1.4M | 9.95% |
3/31/2023 | $ 14.73M | $ 82.37K | 0.56% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
GP / Assets
(=) GPA
GPA for INMED PHARMACEUTICALS INC is calculated as follows: GP [ $ 0 ] / Assets [ $ 6.6M ]
(=) GPA [ 0% ]
Minimum
Jun 30, 2021
Maximum
Dec 31, 2024
Average
Median
filtered constituents | 4.13K |
---|---|
min | -50.32% |
max | 83.98% |
average | 20.16% |
median | 15.35% |
std | 19.94% |